|
|
|
Dear [Full Name]
This is a reminder that you have registered to view a Live Broadcast on
a new treatment option for adult patients with relapsed or refractory
diffuse large B-cell lymphoma (DLBCL), not otherwise specified, including DLBCL arising from follicular lymphoma, after at least 2 lines of systemic therapy.
Thank you for your participation!
For full Prescribing Information, Click Here
|
|
|
|
|
Michael W. Schuster, MD
Professor of Medicine
Stony Brook University Hospital
|
|
|
|
Yair Levy, MD
Director of Heme Malignancies Research
Baylor University Medical Center
|
|
|
|
|
|
|
|
|
|
This Live Broadcast is sponsored by Karyopharm
Therapeutics Inc.
© 2020 Karyopharm Therapeutics Inc. All rights reserved.
US-XPOV-05/20-00030
|
|
|
|
|
Onclive – an MJH Life Sciences brand
Copyright 2020 © Intellisphere, LLC
2 Clarke Drive, Suite 100
Cranbury, NJ 08512
Preferences | Unsubscribe
|
|
|
